期刊文献+

10-23型DNA酶作为鉴定mRNA靶点有效性的新工具 被引量:4

10-23 DNAzyme as a Novel Tool for Verifying the Validity of mRNA Target Sites
下载PDF
导出
摘要 10-23DNA酶是能主动切割mRNA的一类反义寡核苷酸.利用10-23DNA酶的直接切割作用验证mRNA结构靶点的有效性.对筛选的绿色荧光蛋白(GFP)基因mRNA的4个靶点平行设计了4条反义寡核苷酸和4条10-23DNA酶,对照组反义寡核苷酸将最佳靶点——靶点2的反义寡核苷酸突变2个碱基,对照组10-23DNA酶将靶点2的10-23DNA酶结合臂中央突变2个碱基.体外4条10-23DNA酶切割mRNA的结果和相应的4条反义寡核苷酸依赖的RNaseH降解结果完全相似,细胞内4条10-23DNA酶对绿色荧光蛋白的表达抑制作用与相应的4条反义寡核苷酸相似,表明10-23DNA酶显示的最佳作用靶点同样是最佳作用效果的反义寡核苷酸结合靶.10-23DNA酶可以作为评价mRNA结构靶点有效性的新工具. 10-23 DNAzyme is one of antisense oligo-deoxynucleotides (asODNs) which actively split mRNA molecules. The split activity was used for verifying the binding validity of asODNs to different targeting sites on mRNA. For 4 sites on the mRNA of green fluorescence protein (GFP), four asODNs and four 10-23 DNAzymes were designed in parallel. The control asODN had 2 mutation bases from asODN of the best site 2, and control 10-23 DNAzyme contained 2 mutation bases in the binding arms of the 10-23 DNAzyme to site 2. In vitro cleavage of GFP transcript by DNAzyme and asODNs dependent RNase H found that they have the same order in efficacy. After intracellular transfection of HeLa cells with 4 kinds of DNAzymes and 4 asODN, respectively, immuno-fluorescence microscopy examination indicated similar order in knockdown effects by reducing fluorescence intensity with most significant attenuation occurring for A4 and D4.The GFP knock down effectiveness by 10-23 DNAzyme were identical to those of respective asODNs as revealed by flow cytometry. These results suggested that 10-23 DNAzymes may be a novel tool for verifying the validity of target sites on gene mRNA.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2005年第5期622-627,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(30271546) 北京市自然科学基金(5033020)资助项目~~
关键词 10-23 DNA酶 MRNA 靶点 有效性 反义寡核苷酸 绿色荧光蛋白 10-23 DNAzyme, mRNA, target site, validity, antisense oligonucleotide, green fluorescence protein
  • 相关文献

参考文献17

  • 1Bennett C F, Chiang M Y, Wilson-Lingardo L, Wyatt J R. Sequence specific inhibition of human type Ⅱ phospholipase A2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res, 1994, 22 ( 15 ):3202 ~ 3209. 被引量:1
  • 2Cload S T, Schepartz A. Slection of structure-specific inhibitors of the HIV Rev-Rev response element complex. J Am Chem Soc, 1994,116:437 ~ 442. 被引量:1
  • 3Ho S P, Britton D H, Stone B A, Behrens D L, Leffet L M, Hobbs F W, Miller J A, Trainor G L. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res, 1996,24:1901 ~ 1907. 被引量:1
  • 4Lima W F, Brown-Driver V, Fox M, Hanecak R, Bruice T W.Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem, 1997, 272:626 ~ 638. 被引量:1
  • 5Bruice T W, Lima W F. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridyzation sites on structured RNA. Biochemistry, 1997,36:5004 ~ 5019. 被引量:1
  • 6Birikh K R, Berlin Y A, Soreq H, Eckstein F. Probing accessible sites for ribozymes on human acetylcholinesterase. RNA, 1997, 3:429 ~ 437. 被引量:1
  • 7Matveeva O, Felden B, Audlin S, Gesteland R F, Atkins J F. A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures. Nucleic Acids Res, 1997,25:5010 ~ 5016. 被引量:1
  • 8Scherr M, Rossi J J. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. Nucleic Acids Res, 1998,26:5079 ~ 5085. 被引量:1
  • 9Monia B P, Johnston J F, Geiger T, Muller M, Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med, 1996, 2:668 ~ 675. 被引量:1
  • 10Santoro S W, Joyce G F. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA, 1997, 94:4262 ~ 4266. 被引量:1

二级参考文献51

  • 1韩慧明,毛建平.siRNA作用效果的靶点依赖性[J].中国生物工程杂志,2004,24(12):6-9. 被引量:5
  • 2SambrookJ RussellDW 黄培堂 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.32-50. 被引量:30
  • 3Looney D, Yu M. Clinical aspects of ribozymes as therapeutics in gene therapy. Methods Mol Biol, 1997, 74:469 - 486 被引量:1
  • 4Yacyshyn B R, Bowen-Yacyshyn M B, Jewell L, Tami J A, Bennett C F, Kisner D L, Shanahan W R Jr. A placebo-controlled trial of ICAMI antisense oligonucleotide in the treatment of Crohn's disease.Gastroenterology, 1998, 114:1133 ~ 1142 被引量:1
  • 5Stasiak A. Getting down to the core of homologous recombination.Science, 1996, 272:828 - 829 被引量:1
  • 6Luo Z, Macris M A, Faruqi A F, Glazer P M. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA, 2000, 97: 9003 - 9000 被引量:1
  • 7Knauert M P, Glazer P M. Triplex forming oligonucleotides: sequencespecific tools for gene targeting. Hum Mol Genet, 2001, 10:2243 -2251 被引量:1
  • 8Sharma H W, Perez J R, Higgins-Sochaski K, Hsiao R, Narayanan R.Transcription factor decoy approach to decipher the role of NF-B in oncogenesis. Anticancer Res, 1996, 16:61 - 69 被引量:1
  • 9Rossi J J. Ribozymes, genomics and therapeutics. Chem Biol, 1999,6: R33 - R37 被引量:1
  • 10Persidis A. Ribozyme therapeutics. Nat Biotech, 1997, 15(9):921-922 被引量:1

共引文献11

同被引文献46

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部